CytomX Therapeutics (CTMX) Earnings Call Transcripts
Price: $0.5325
Market Cap: $42.65M
Avg Volume: 1.81M
Market Cap: $42.65M
Avg Volume: 1.81M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-03-06 | $-0.20 | $0.22 |
| Read Transcript | Q2 | 2024 | 2024-08-09 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-05-08 | $-0.08 | $0.17 |
| Read Transcript | Q4 | 2023 | 2024-03-11 | $0.00 | $0.01 |
| Read Transcript | Q3 | 2023 | 2023-11-08 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-08-08 | $-0.19 | $-0.02 |
| Read Transcript | Q1 | 2023 | 2023-05-09 | $-0.16 | $-0.05 |
| Read Transcript | Q4 | 2022 | 2023-03-27 | $-0.21 | $-0.42 |
| Read Transcript | Q3 | 2022 | 2022-11-08 | $-0.32 | $-0.35 |
| Read Transcript | Q2 | 2022 | 2022-08-05 | N/A | N/A |
| Read Transcript | Q1 | 2022 | 2022-05-07 | N/A | N/A |
| Read Transcript | Q4 | 2021 | 2022-03-01 | $-0.25 | $-0.40 |
| Read Transcript | Q3 | 2021 | 2021-11-07 | N/A | N/A |
| Read Transcript | Q2 | 2021 | 2021-08-08 | N/A | N/A |
| Read Transcript | Q1 | 2021 | 2021-05-09 | N/A | N/A |
| Read Transcript | Q4 | 2020 | 2021-02-24 | $-0.35 | $-0.31 |
| Read Transcript | Q3 | 2020 | 2020-11-07 | N/A | N/A |
| Read Transcript | Q2 | 2020 | 2020-08-08 | N/A | N/A |
| Read Transcript | Q1 | 2020 | 2020-05-10 | N/A | N/A |
| Read Transcript | Q4 | 2019 | 2020-02-28 | N/A | N/A |
| Read Transcript | Q3 | 2019 | 2019-11-07 | $-0.39 | $-0.52 |
| Read Transcript | Q2 | 2019 | 2019-08-08 | N/A | N/A |
| Read Transcript | Q1 | 2019 | 2019-05-09 | $-0.53 | $-0.31 |
| Read Transcript | Q4 | 2018 | 2019-02-27 | $-0.49 | $-0.72 |
| Read Transcript | Q3 | 2018 | 2018-11-11 | N/A | N/A |
| Read Transcript | Q4 | 2017 | 2018-03-07 | $-0.43 | $0.02 |
| Read Transcript | Q2 | 2017 | 2017-08-07 | $-0.39 | $-0.69 |